Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

SARS-CoV-2 is an emerging virus from the Coronaviridae family and is responsible for the ongoing COVID-19 pandemic. In this work, we explored the previously reported SARS-CoV-2 structural membrane protein (M) interaction with human Proliferating Cell Nuclear Antigen (PCNA). The M protein is responsible for maintaining virion shape, and PCNA is a marker of DNA damage which is essential for DNA replication and repair. We validated the M-PCNA interaction through immunoprecipitation, immunofluorescence co-localization, and PLA (Proximity Ligation Assay). In cells infected with SARS-CoV-2 or transfected with M protein, using immunofluorescence and cell fractioning, we documented a reallocation of PCNA from the nucleus to the cytoplasm and the increase of PCNA and γH2AX (another DNA damage marker) expression. We also observed an increase in PCNA and γH2AX expression in the lung of a COVID-19 patient by immunohistochemistry. In addition, the inhibition of PCNA translocation by PCNA I1 and Verdinexor led to a reduction of plaque formation in an in vitro assay. We, therefore, propose that the transport of PCNA to the cytoplasm and its association with M could be a virus strategy to manipulate cell functions and may be considered a target for COVID-19 therapy. Copyright © 2022 Zambalde, Pavan, Mancini, Severino, Scudero, Morelli, Amorim, Bispo-dos-Santos, Góis, Toledo-Teixeira, Parise, Mauad, Dolhnikoff, Saldiva, Marques-Souza, Proenca-Modena, Ventura and Simabuco.

Citation

Érika Pereira Zambalde, Isadora Carolina Betim Pavan, Mariana Camargo Silva Mancini, Matheus Brandemarte Severino, Orlando Bonito Scudero, Ana Paula Morelli, Mariene Ribeiro Amorim, Karina Bispo-Dos-Santos, Mariana Marcela Góis, Daniel A Toledo-Teixeira, Pierina Lorencini Parise, Thais Mauad, Marisa Dolhnikoff, Paulo Hilário Nascimento Saldiva, Henrique Marques-Souza, José Luiz Proenca-Modena, Armando Morais Ventura, Fernando Moreira Simabuco. Characterization of the Interaction Between SARS-CoV-2 Membrane Protein (M) and Proliferating Cell Nuclear Antigen (PCNA) as a Potential Therapeutic Target. Frontiers in cellular and infection microbiology. 2022;12:849017

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 35677658

View Full Text